Clincosm LogoSign in Get a demo

gastric cancer

Showing NaN - NaN of 45
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer, Hepatocellular Cancer, Squamous Cell Cancer (SCC) Trial in United States (TAK-500, Pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +9 more
  • Duarte, California
  • +6 more
Jan 17, 2023

Advanced Solid Tumor, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in United States (STK-012,

Recruiting
  • Advanced Solid Tumor
  • +10 more
  • Boston, Massachusetts
  • +8 more
Jan 2, 2023

Gastric Cancer Trial in Worldwide (Bemarituzumab, Placebo, Modified FOLFOX6)

Completed
Has Results
  • Gastric Cancer
  • Bemarituzumab
  • +2 more
  • Tucson, Arizona
  • +188 more
Dec 15, 2022

Pancreatic Cancer, Esophageal Cancer, Gastric Cancer Trial in Boston (Usual Care, Perioperative Geriatrics Intervention)

Completed
  • Pancreatic Cancer
  • +5 more
  • Usual Care
  • Perioperative Geriatrics Intervention
  • Boston, Massachusetts
    Massachusetts general Hospital
Nov 18, 2022

Oesophageal Squamous Cell Carcinoma, Gastric Cancer, Hepatocellular Carcinoma Trial in Worldwide (THOR-707, Pembrolizumab,

Active, not recruiting
  • Oesophageal Squamous Cell Carcinoma
  • +4 more
  • Duarte, California
  • +39 more
Oct 31, 2022

Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer Trial in Worldwide (margetuximab, Retifanlimab,

Active, not recruiting
  • Gastric Cancer
  • +2 more
  • margetuximab
  • +4 more
  • Scottsdale, Arizona
  • +72 more
Aug 24, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

Colorectal Cancer, Pancreatic Cancer, Esophageal Cancer Trial in Boston (LUM015, LUM 2.6 Imaging Device)

Recruiting
  • Colorectal Cancer
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Aug 15, 2022

Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in China, United States (TJ033721)

Recruiting
  • Solid Tumor
  • +6 more
  • Orange, California
  • +17 more
Aug 9, 2022

Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan

Not yet recruiting
  • Endometrial Cancer
  • +4 more
  • Datopotamab deruxtecan (Dato-DXd)
  • +8 more
  • Los Angeles, California
  • +52 more
Aug 3, 2022

Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC) Trial in Worldwide (INCB001158, Pembrolizumab)

Active, not recruiting
Has Results
  • Metastatic Cancer
  • +9 more
  • Mobile, Alabama
  • +19 more
Aug 1, 2022

Ovarian Cancer, Breast Cancer, Lung Cancer Trial in Boston, Omaha, Columbus (Digital Health Coaching Program, Fitbit)

Recruiting
  • Ovarian Cancer
  • +4 more
  • Digital Health Coaching Program
  • Fitbit
  • Boston, Massachusetts
  • +2 more
Jul 13, 2022

Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (Combination of NKTR-214 + nivolumab)

Completed
  • Melanoma
  • +6 more
  • Combination of NKTR-214 + nivolumab
  • La Jolla, California
  • +57 more
Jun 22, 2022

ER+ Breast Cancer, CCNE1 Amplification, HER2-negative Breast Cancer Trial in United States (BLU-222, Carboplatin, Ribociclib)

Recruiting
  • ER+ Breast Cancer
  • +8 more
  • Sarasota, Florida
  • +3 more
Jun 8, 2022

NSCLC, Small Cell Lung Cancer, Urothelial Carcinoma Trial in United States (N-803 + Pembrolizumab, N-803 + Nivolumab, N-803 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • N-803 + Pembrolizumab
  • +9 more
  • Anchorage, Alaska
  • +34 more
Apr 4, 2022

Esophageal Cancer, Gastric Cancer Trial in United States (Afatinib and Paclitaxel)

Active, not recruiting
  • Esophageal Cancer
  • Gastric Cancer
  • Afatinib and Paclitaxel
  • Los Angeles, California
  • +8 more
Mar 18, 2022

Gastric Cancer Trial in Worldwide (5-Fluorouracil, Ipatasertib, Leucovorin)

Completed
Has Results
  • Gastric Cancer
  • Los Angeles, California
  • +33 more
Feb 18, 2022

Cholangiocarcinoma, Urothelial Cancer, Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors Trial in

Active, not recruiting
  • Cholangiocarcinoma
  • +5 more
  • Gilbert, Arizona
  • +57 more
Jan 5, 2022

Advanced Solid Tumors, Gastric Cancer, Transitional Cell Carcinoma of the Bladder Trial in Korea, Republic of, Taiwan, United

Completed
Has Results
  • Advanced Solid Tumors
  • +2 more
  • Duarte, California
  • +25 more
Dec 9, 2021

Liver Cancer, Anxiety Disorder, Depression Trial in United States (Early palliative care)

Completed
Has Results
  • Liver Cancer
  • +9 more
  • Early palliative care
  • La Jolla, California
  • +22 more
Jul 22, 2021

Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Taiwan, United States (AbGn-107)

Terminated
  • Gastric Cancer
  • +3 more
  • AbGn-107
  • Phoenix, Arizona
  • +8 more
Jul 8, 2021

Esophageal Cancer, Gastric Cancer, Stomach Cancer Trial in Boston, Nashville, Dallas (Bevacizumab, Cisplatin, Irinotecan)

Active, not recruiting
Has Results
  • Esophageal Cancer
  • +2 more
  • Boston, Massachusetts
  • +3 more
Jul 7, 2021

Breast Cancer, Gastric Cancer, Solid Tumors Trial in United States (Pyrotinib)

Unknown status
  • Breast Cancer
  • +3 more
  • Orange, California
  • +9 more
Jan 28, 2021

Dose Escalation, Safety, Preliminary Efficacy Trial in Worldwide (LDE225, BKM120)

Completed
  • Dose Escalation
  • +11 more
  • Los Angeles, California
  • +22 more
Dec 16, 2020

NSCLC, Small Cell Lung Cancer, Mesothelioma Trial in Boston (early palliative care)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • +6 more
  • early palliative care
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 20, 2020